The main purpose of the Screening Group is to provide hit identification and hit-to-lead optimization contract services to the biotech and pharmaceutical industry. We are also open to discuss shared-risk exploratory hit finding projects with the industry or academic partners… (more…)

In 2011, Enamine announced opening of a contract research laboratory (CRO) for bioscreening and ADMET testing services at its main research site in Kiev, Ukraine.  Since June 2013, Enamine’s biological testing services are offered under a trademark of Bienta. (more…)

The growing Bienta currently employs 18 FTEs and is capable of performing HTS with a broad variety of biochemical and cell-based assays… (more…)